Russell Investments Group
SPRO icon

Russell Investments Group’s Spero Therapeutics SPRO Stock Holding History

Russell Investments Group’s Portfolio SPRO Stock Details SPRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,400
Closed -$8.58K – 3784
2024
Q3 		$8.58K Hold
6,400
– – ﹤0.01% 3120
2024
Q2 		$8.32K Hold
6,400
– – ﹤0.01% 3114
2024
Q1 		$11K Hold
6,400
– – ﹤0.01% 2840
2023
Q4 		$9.41K Hold
6,400
– – ﹤0.01% 2832
2023
Q3 		$7.74K Hold
6,400
– – ﹤0.01% 3069
2023
Q2 		$9.28K Hold
6,400
– – ﹤0.01% 2977
2023
Q1 		$9.28K Hold
6,400
– – ﹤0.01% 2896
2022
Q4 		$11.1K Hold
6,400
– – ﹤0.01% 2839
2022
Q3 		$12K Hold
6,400
– – ﹤0.01% 2851
2022
Q2 		$4K Sell
6,400
-850
-12% -$2.47K ﹤0.01% 2858
2022
Q1 		$63K Hold
7,250
– – ﹤0.01% 2614
2021
Q4 		$116K Sell
7,250
-897
-11% -$14.2K ﹤0.01% 2820
2021
Q3 		$149K Sell
8,147
-9,222
-53% -$148K ﹤0.01% 2822
2021
Q2 		$241K Sell
17,369
-31,798
-65% -$444K ﹤0.01% 2850
2021
Q1 		$723K Sell
49,167
-2,600
-5% -$45.8K ﹤0.01% 2370
2020
Q4 		$1M Sell
51,767
-64,761
-56% -$1.01M ﹤0.01% 2116
2020
Q3 		$1.29M Buy
116,528
+23,200
+25% +$274K ﹤0.01% 1938
2020
Q2 		$1.26M Buy
93,328
+82,587
+769% +$927K ﹤0.01% 1915
2020
Q1 		$86K Buy
10,741
+4,873
+83% +$43K ﹤0.01% 2771
2019
Q4 		$55K Buy
+5,868
New +$63.3K ﹤0.01% 2984
2018
Q4 		– Sell
-1,300
Closed -$14K – 3027
2018
Q3 		$14K Sell
1,300
-700
-35% -$8.12K ﹤0.01% 2917
2018
Q2 		$29K Buy
+2,000
New +$25.6K ﹤0.01% 2861

Other funds holding SPRO

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group's SPRO Position: Q4 2024 in Review

Russell Investments Group sold out of Spero Therapeutics (SPRO) in Q4 2024, closing a stake of 6,400 shares — an estimated $8.58K sold.

Russell Investments Group first reported a position in SPRO in Q2 2018 and held it in 22 quarters. The position peaked at $1.29M in Q3 2020. 50 funds tracked by Wall St. Rank hold SPRO as of Q4 2024.

  • Russell Investments Group reported no remaining Spero Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Russell Investments Group sold 6,400 Spero Therapeutics shares in Q4 2024, an estimated $8.58K.
  • Russell Investments Group first reported a position in Spero Therapeutics in Q2 2018 and held it in 22 quarters.
  • Russell Investments Group's Spero Therapeutics position peaked at $1.29M in Q3 2020.
  • 50 funds tracked by Wall St. Rank held Spero Therapeutics as of Q4 2024.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.